MedPage Today on MSN
Dual Immunotherapy and Liver Perfusion Delays Progression in Uveal Melanoma
Ipilimumab-nivolumab also linked with better survival but more toxicity in small study ...
The study highlights that combining the DecisionDx-UM test with PRAME expression is superior to standard mutation analysis. And for a patient who's just been diagnosed with uveal melanoma, what does ...
“The present studies demonstrated that GZ17-6.02 interacted with irreversible inhibitors of the EGF receptor and HER2 to kill uveal melanoma cells.” BUFFALO, NY- May 22, 2024 – A new research paper ...
ROCHESTER, Minnesota — Mayo Clinic researchers have developed organoid models to study uveal melanoma, one of the most common types of eye cancer in adults. Their goal is to use these models to better ...
A new study demonstrates the effectiveness of a widely-used eye injection to manage the previously untreatable rare condition, hypotony, in a project by clinical researchers at UCL and Moorfields Eye ...
The Hepzato Kit is the first FDA-approved liver-directed therapy for unresectable metastatic uveal melanoma, showing consistent efficacy across diverse patient subgroups. Patients with lower tumor ...
Servier and IDEAYA Biosciences (IDYA) enter into an exclusive license agreement for regulatory and commercial rights to darovasertib outside the US Darovasertib is a small molecule developed for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results